Fingolimod Capsule
Product Images NDC 62756-064

Fingolimod Capsules contain 0.56 mg of fingolimod hydrochloride USP equivalent to 0.5 mg of fingolimod per capsule. The recommended dosage can be found in the package insert. The medication should be stored between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C and 30°C (59°F and 86°F). It should be protected from moisture and the child-resistant packaging should not be used if the blister is open or torn. A medication guide is available online from the manufacturer. Sun Pharmaceutical Industries Ltd. located in Guijarat, India produces this medication; it is distributed in the United States by Sun Pharmaceutical Industries, Inc. in Cranbury, NJ.*

This is a medication called Fingolimod provided in capsule form. Each capsule contains 0.56mg of fingolimod hydrochloride USP that is equivalent to 0.5mg of fingolimod. The typical dose should be taken as per the package insert. The medicine should be stored between 20°C to 25°C (68°F to 77°F) and safeguarded from moisture. The child-resistant pack must not be used in case an individual blister unit is open or torn. The manufacturer of this medication is Sun Pharmaceutical Industries Ltd. Visit https://www.sunpharma.com/usa/products for more information. The medication guide should be provided to each patient along with the medication. The product is meant only for prescription use. Expiration date needs to be printed.*

This is a medication called Fingolimod Capsules with a usual dosage given in a package insert. It must be kept out of reach of children and protected from moisture. The medication guide is available on the website of the manufacturer, Sun Pharmaceutical Industries. Each capsule has 0.56mg of fingolimod hydrochloride USP. The manufacturer is located in Gujarat, India. The text also includes information on how to store the medication.*

Each capsule of the medicine Fingolimod contains 0.56mg of fingolimod hydrochloride USP, which is equal to 0.5mg of fingolimod. The standard dosage is mentioned in the package insert. The medicine should be stored at a temperature between 20°C to 25°C, and it should be protected from moisture. The package is child-resistant, and if the individual blister unit is open or torn, the medicine should not be used. The medicine is manufactured by Sun Pharmaceutical Industries in Gujarat, India, and it is distributed by Sun Pharmaceutical Industries, Inc. in Cranbury, NJ, USA. The package contains 28 unit-dose capsules, meant to be a four-week supply. An expiry date needs to be overprinted. Medication Guide can be found at https://www.sunpharma.com/usa/products. NDC code for the medicine is 62756-064-57. Pharmacists are advised to dispense the medication guide to each patient.*

This is a description of fingolimod capsules, including dosage information and safety precautions. Each capsule contains 0.56mg of fingolimod hydrochloride USP equivalent to 0.5mg of fingolimod. The medication should be kept out of reach of children and protected from moisture. It should be stored at 20°C to 25°C (68°F to 77°F), with excursions between 15°C and 30°C (59°F and 86°F) permitted. The pharmacist is advised to dispense the medication with a medication guide for each patient. The product is distributed by Sun Pharmaceutical Industries, Inc. and is manufactured by Sun Pharmaceutical Industries Ltd. in Gujarat, India. Information such as the drug’s NDC, lot number, expiration date, and more is also included.*